Timing of initiation of anti-retroviral therapy predicts post-treatment control of SIV replication is a research paper published in PLoS Pathogens (2023). On theSindex it has a DataRank of 0. It has been cited 17 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
Grant: P01AI131338
Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
Grant: R21/R33AI116171, NHLBI, NIDDK, NIMH, NINDS, NIDA, NIAID, UM1AI164562, NIAID U42OD011023, and P51OD011132
National Health and Medical Research Council
Grant: 1173027 and 1149990
Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
Grant: UM1AI126611, P51OD011092 and AI144993
National Cancer Institute, National Institutes of Health
Grant: 75N91019D00024 and HHSN261201500003I
NIH HHS
Grant: U42 OD011023
NCI NIH HHS
Grant: HHSN261201500003C
NCI NIH HHS
Grant: HHSN261201500003I
NCI NIH HHS
Grant: 75N91019D00024
NIH HHS
Grant: P51 OD011092
NIH HHS
Grant: P51 OD011132
NIAID NIH HHS
Grant: UM1 AI164562
NIAID NIH HHS
Grant: UM1 AI126611
NIAID NIH HHS
Grant: R21 AI116171
NIAID NIH HHS
Grant: R33 AI116171
National Institutes of Health
Grant: 5P01AI131338-05
Immunological Strategies to Modulate SIV Rebound Following ART Interruption
National Institutes of Health
Grant: 5UM1AI164562-03
Enterprise for Research and Advocacy to Stop and Eradicate HIV (ERASE-HIV)
National Institutes of Health
Grant: 4R33AI116171-03
Targeting Cytolytic Cells to Lymphoid Sites of HIV Persistence.
National Institutes of Health
Grant: 3P51OD011132-64S2
Renovation to expand and enhance NHP housing for HIV/AIDS research at the Emory NPRC
National Institutes of Health
Grant: 3P51OD011092-55S1
SUPPORT FOR NATIONAL PRIMATE RESEARCH CENTER
National Institutes of Health
Grant: 3U42OD011023-19S1
Maintenance of the SPF Breeding Colonies at Yerkes National Primate Research Center
National Institutes of Health
Grant: 5UM1AI126611-05
Delaney AIDS Research Enterprise to Cure HIV
National Health and Medical Research Council (NHMRC)
Grant: 1149990
Addressing the major challenges in HIV vaccine and cure research
FWCI
2.08
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals